![A comparative effectiveness analysis of the PBCG vs. PCPT risks calculators in a multi-ethnic cohort | BMC Urology | Full Text A comparative effectiveness analysis of the PBCG vs. PCPT risks calculators in a multi-ethnic cohort | BMC Urology | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs12894-019-0553-6/MediaObjects/12894_2019_553_Fig2_HTML.png)
A comparative effectiveness analysis of the PBCG vs. PCPT risks calculators in a multi-ethnic cohort | BMC Urology | Full Text
![Head-to-head Comparison of Conventional, and Image- and Biomarker-based Prostate Cancer Risk Calculators - European Urology Focus Head-to-head Comparison of Conventional, and Image- and Biomarker-based Prostate Cancer Risk Calculators - European Urology Focus](https://www.eu-focus.europeanurology.com/cms/asset/a9ff3c6d-b2c8-4218-97ab-9d8b49da6cee/gr1.jpg)
Head-to-head Comparison of Conventional, and Image- and Biomarker-based Prostate Cancer Risk Calculators - European Urology Focus
![4kscore test, prostate cancer prevention trial-risk calculator y european research screening prostate-risk calculator en la predicción del cáncer de próstata de alto grado; estudio preliminar - Repositorio Institucional de Documentos 4kscore test, prostate cancer prevention trial-risk calculator y european research screening prostate-risk calculator en la predicción del cáncer de próstata de alto grado; estudio preliminar - Repositorio Institucional de Documentos](https://zaguan.unizar.es/record/78052/files/texto_completo.jpg?subformat=icon)
4kscore test, prostate cancer prevention trial-risk calculator y european research screening prostate-risk calculator en la predicción del cáncer de próstata de alto grado; estudio preliminar - Repositorio Institucional de Documentos
![Incorporation of Urinary Prostate Cancer Antigen 3 and TMPRSS2:ERG into Prostate Cancer Prevention Trial Risk Calculator - European Urology Focus Incorporation of Urinary Prostate Cancer Antigen 3 and TMPRSS2:ERG into Prostate Cancer Prevention Trial Risk Calculator - European Urology Focus](https://www.eu-focus.europeanurology.com/cms/attachment/adf2d3f5-f120-4033-88a6-3fc175a7a0aa/gr1.jpg)
Incorporation of Urinary Prostate Cancer Antigen 3 and TMPRSS2:ERG into Prostate Cancer Prevention Trial Risk Calculator - European Urology Focus
![Predicting the risk of prostate cancer in asymptomatic men: a cohort study to develop and validate a novel algorithm | British Journal of General Practice Predicting the risk of prostate cancer in asymptomatic men: a cohort study to develop and validate a novel algorithm | British Journal of General Practice](https://bjgp.org/content/bjgp/71/706/e364/F1.large.jpg)
Predicting the risk of prostate cancer in asymptomatic men: a cohort study to develop and validate a novel algorithm | British Journal of General Practice
![External Validation of the Rotterdam Prostate Cancer Risk Calculator and Comparison with Stockholm3 for Prostate Cancer Diagnosis in a Swedish Population-based Screening Cohort - European Urology Focus External Validation of the Rotterdam Prostate Cancer Risk Calculator and Comparison with Stockholm3 for Prostate Cancer Diagnosis in a Swedish Population-based Screening Cohort - European Urology Focus](https://www.eu-focus.europeanurology.com/cms/attachment/1c9dc49e-b7f0-494a-8696-a6fff2ae90ed/gr2_lrg.jpg)
External Validation of the Rotterdam Prostate Cancer Risk Calculator and Comparison with Stockholm3 for Prostate Cancer Diagnosis in a Swedish Population-based Screening Cohort - European Urology Focus
![The prostate cancer prevention trial risk calculator 2.0 performs equally for standard biopsy and MRI/US fusion-guided biopsy | Prostate Cancer and Prostatic Diseases The prostate cancer prevention trial risk calculator 2.0 performs equally for standard biopsy and MRI/US fusion-guided biopsy | Prostate Cancer and Prostatic Diseases](https://media.springernature.com/lw685/springer-static/image/art%3A10.1038%2Fpcan.2016.46/MediaObjects/41391_2017_Article_BFpcan201646_Fig1_HTML.jpg)
The prostate cancer prevention trial risk calculator 2.0 performs equally for standard biopsy and MRI/US fusion-guided biopsy | Prostate Cancer and Prostatic Diseases
![Improving patient prostate cancer risk assessment: Moving from static, globally-applied to dynamic, practice-specific risk calculators - ScienceDirect Improving patient prostate cancer risk assessment: Moving from static, globally-applied to dynamic, practice-specific risk calculators - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S1532046415000805-fx1.jpg)
Improving patient prostate cancer risk assessment: Moving from static, globally-applied to dynamic, practice-specific risk calculators - ScienceDirect
![A comparative effectiveness analysis of the PBCG vs. PCPT risks calculators in a multi-ethnic cohort | BMC Urology | Full Text A comparative effectiveness analysis of the PBCG vs. PCPT risks calculators in a multi-ethnic cohort | BMC Urology | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs12894-019-0553-6/MediaObjects/12894_2019_553_Fig3_HTML.png)
A comparative effectiveness analysis of the PBCG vs. PCPT risks calculators in a multi-ethnic cohort | BMC Urology | Full Text
![The prostate cancer prevention trial risk calculator 2.0 performs equally for standard biopsy and MRI/US fusion-guided biopsy | Prostate Cancer and Prostatic Diseases The prostate cancer prevention trial risk calculator 2.0 performs equally for standard biopsy and MRI/US fusion-guided biopsy | Prostate Cancer and Prostatic Diseases](https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fpcan.2016.46/MediaObjects/41391_2017_Article_BFpcan201646_Fig1_HTML.jpg)
The prostate cancer prevention trial risk calculator 2.0 performs equally for standard biopsy and MRI/US fusion-guided biopsy | Prostate Cancer and Prostatic Diseases
![The prostate cancer prevention trial risk calculator 2.0 performs equally for standard biopsy and MRI/US fusion-guided biopsy | Prostate Cancer and Prostatic Diseases The prostate cancer prevention trial risk calculator 2.0 performs equally for standard biopsy and MRI/US fusion-guided biopsy | Prostate Cancer and Prostatic Diseases](https://media.springernature.com/lw685/springer-static/image/art%3A10.1038%2Fpcan.2016.46/MediaObjects/41391_2017_Article_BFpcan201646_Fig2_HTML.jpg)
The prostate cancer prevention trial risk calculator 2.0 performs equally for standard biopsy and MRI/US fusion-guided biopsy | Prostate Cancer and Prostatic Diseases
![IJMS | Free Full-Text | Prediction Medicine: Biomarkers, Risk Calculators and Magnetic Resonance Imaging as Risk Stratification Tools in Prostate Cancer Diagnosis IJMS | Free Full-Text | Prediction Medicine: Biomarkers, Risk Calculators and Magnetic Resonance Imaging as Risk Stratification Tools in Prostate Cancer Diagnosis](https://pub.mdpi-res.com/ijms/ijms-20-01637/article_deploy/html/images/ijms-20-01637-g001-550.jpg?1571315946)
IJMS | Free Full-Text | Prediction Medicine: Biomarkers, Risk Calculators and Magnetic Resonance Imaging as Risk Stratification Tools in Prostate Cancer Diagnosis
![Prostate Cancer Prevention Trial Risk Calculator 2.0 for the Prediction of Low- vs High-grade Prostate Cancer - ScienceDirect Prostate Cancer Prevention Trial Risk Calculator 2.0 for the Prediction of Low- vs High-grade Prostate Cancer - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0090429514002490-gr1.jpg)
Prostate Cancer Prevention Trial Risk Calculator 2.0 for the Prediction of Low- vs High-grade Prostate Cancer - ScienceDirect
![PDF] Assessing prostate cancer risk: results from the Prostate Cancer Prevention Trial. | Semantic Scholar PDF] Assessing prostate cancer risk: results from the Prostate Cancer Prevention Trial. | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/d1cf7f1b5d3cefd5cd5ecbba3b2a59fadd0cd490/4-Figure1-1.png)
PDF] Assessing prostate cancer risk: results from the Prostate Cancer Prevention Trial. | Semantic Scholar
![PDF] Assessing prostate cancer risk: results from the Prostate Cancer Prevention Trial. | Semantic Scholar PDF] Assessing prostate cancer risk: results from the Prostate Cancer Prevention Trial. | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/d1cf7f1b5d3cefd5cd5ecbba3b2a59fadd0cd490/4-Figure2-1.png)
PDF] Assessing prostate cancer risk: results from the Prostate Cancer Prevention Trial. | Semantic Scholar
![Adaptation and external validation of the European randomised study of screening for prostate cancer risk calculator for the Chinese population | Prostate Cancer and Prostatic Diseases Adaptation and external validation of the European randomised study of screening for prostate cancer risk calculator for the Chinese population | Prostate Cancer and Prostatic Diseases](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fpcan.2016.57/MediaObjects/41391_2017_Article_BFpcan201657_Fig1_HTML.jpg)